FTC Takes TruHeight’s Growth Claims Down a Few Pegs
Supplement maker agrees to pay $750K to settle deceptive health claims lawsuit.
A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca. They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium. In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)
Supplement maker agrees to pay $750K to settle deceptive health claims lawsuit.
Settlement comes after TINA.org exposed thousands of deceptive income claims.
TINA.org sheds light on confusing and misleading brightness claims.
Brant James, Ingame
Company becomes the latest to leave the industry.